Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 14332 CL Powder in Healthy Male Subjects
Clinical trial NCT02211989 · COMPLETED
Trial details
- NCT number
- NCT02211989
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2006-04-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.